Accuracy of fine needle aspiration cytology (FNAC) of axillary lymph nodes as a triage test in breast cancer staging.

PubWeight™: 1.29‹?› | Rank: Top 10%

🔗 View Article (PMID 17033920)

Published in Breast Cancer Res Treat on October 11, 2006

Authors

Stefano Ciatto1, Beniamino Brancato, Gabriella Risso, Daniela Ambrogetti, Paolo Bulgaresi, Cristina Maddau, Patricia Turco, Nehmat Houssami

Author Affiliations

1: Centro per lo Studio e la Prevenzione Oncologica (CSPO), Florence, Italy.

Articles citing this

Axillary Ultrasound After Neoadjuvant Chemotherapy and Its Impact on Sentinel Lymph Node Surgery: Results From the American College of Surgeons Oncology Group Z1071 Trial (Alliance). J Clin Oncol (2015) 2.28

Selective application of routine preoperative axillary ultrasonography reduces costs for invasive breast cancers. Oncologist (2011) 1.42

Identification and Resection of Clipped Node Decreases the False-negative Rate of Sentinel Lymph Node Surgery in Patients Presenting With Node-positive Breast Cancer (T0-T4, N1-N2) Who Receive Neoadjuvant Chemotherapy: Results From ACOSOG Z1071 (Alliance). Ann Surg (2016) 1.30

Scientific Presentation Award: The combination of axillary ultrasound and ultrasound-guided biopsy is an accurate predictor of axillary stage in clinically node-negative breast cancer patients. Am J Surg (2008) 0.99

Efficiency of ultrasound and ultrasound-guided fine needle aspiration cytology in preoperative assessment of axillary lymph node metastases in breast cancer. J Breast Cancer (2012) 0.90

Utilization and cost of diagnostic imaging and biopsies following positive screening mammography in the southern breast cancer screening region of the Netherlands, 2000-2005. Eur Radiol (2008) 0.88

Staging the axilla in women with breast cancer: the utility of preoperative ultrasound-guided needle biopsy. Cancer Biol Med (2014) 0.87

Evaluation of the metastatic status of lymph nodes identified using axillary reverse mapping in breast cancer patients. World J Surg Oncol (2012) 0.83

Fine-needle aspirates CYFRA 21-1 is a useful tumor marker for detecting axillary lymph node metastasis in breast cancer patients. PLoS One (2013) 0.80

Diagnostic value of preoperative axillary lymph node ultrasound assessment in patients with breast cancer qualified for sentinel lymph node biopsy. Wideochir Inne Tech Maloinwazyjne (2015) 0.77

Accuracy of individual descriptors and grading of nodal involvement by axillary ultrasound in patients of breast cancer. Int J Breast Cancer (2013) 0.77

Fine-needle aspirate CYFRA 21-1, an innovative new marker for diagnosis of axillary lymph node metastasis in breast cancer patients. Medicine (Baltimore) (2015) 0.75

Predictive value of fine needle aspiration biopsy of axillary lymph nodes in preoperative breast cancer staging. Ulus Cerrahi Derg (2016) 0.75

Cost/Accuracy ratio analysis in breast cancer patients undergoing ultrasound-guided fine-needle aspiration cytology, sentinel node biopsy, and frozen section of node. World J Surg (2008) 0.75

Diagnostic Accuracy and Impact on Management of Ultrasonography-Guided Fine-Needle Aspiration to Detect Axillary Metastasis in Breast Cancer Patients: A Prospective Study. Breast Care (Basel) (2015) 0.75

Pre-operative axillary staging: should core biopsy be preferred to fine needle aspiration cytology? Ecancermedicalscience (2017) 0.75

HER2 expression in fine needle aspirates of lymph nodes detected by preoperative axillary ultrasound in breast cancer patients. PLoS One (2014) 0.75

Comparative study between ultrasound-guided fine needle aspiration cytology of axillary lymph nodes and sentinel lymph node histopathology in early-stage breast cancer. Oncol Lett (2017) 0.75

Indocyanine green detects sentinel lymph nodes in early breast cancer. J Int Med Res (2017) 0.75

Articles by these authors

Effects of study methods and biases on estimates of invasive breast cancer overdetection with mammography screening: a systematic review. Lancet Oncol (2007) 3.49

Model of outcomes of screening mammography: information to support informed choices. BMJ (2005) 2.86

Integration of 3D digital mammography with tomosynthesis for population breast-cancer screening (STORM): a prospective comparison study. Lancet Oncol (2013) 2.52

Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates. J Natl Cancer Inst (2005) 2.51

Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. J Clin Oncol (2014) 2.38

Four-year results of low-dose CT screening and nodule management in the ITALUNG trial. J Thorac Oncol (2013) 2.32

Women's views on overdiagnosis in breast cancer screening: a qualitative study. BMJ (2013) 2.25

A novel case-control design to estimate the extent of over-diagnosis of breast cancer due to organised population-based mammography screening. Int J Cancer (2014) 2.00

The Society of Surgical Oncology-American Society for Radiation Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Stages I and II Invasive Breast Cancer: Perspectives for Pathologists. Arch Pathol Lab Med (2014) 1.98

Incidence of metastatic breast cancer in an Australian population-based cohort of women with non-metastatic breast cancer at diagnosis. Med J Aust (2012) 1.95

Informed choice in mammography screening: a randomized trial of a decision aid for 70-year-old women. Arch Intern Med (2007) 1.93

Underestimation of malignancy of breast core-needle biopsy: concepts and precise overall and category-specific estimates. Cancer (2007) 1.75

Correcting for lead time and length bias in estimating the effect of screen detection on cancer survival. Am J Epidemiol (2008) 1.71

Ductal carcinoma in situ at core-needle biopsy: meta-analysis of underestimation and predictors of invasive breast cancer. Radiology (2011) 1.59

Magnetic resonance imaging screening of the contralateral breast in women with newly diagnosed breast cancer: systematic review and meta-analysis of incremental cancer detection and impact on surgical management. J Clin Oncol (2009) 1.58

Helping women make choices about mammography screening: an online randomized trial of a decision aid for 40-year-old women. Patient Educ Couns (2010) 1.48

EUSOMA criteria for performing pre-operative MRI staging in candidates for breast conserving surgery: hype or helpful? Breast (2012) 1.48

Life after breast cancer. Aust Fam Physician (2006) 1.43

Would the real breast cancer please stand up? A global perspective of breast cancer. Breast (2008) 1.42

A first evaluation of breast radiological density assessment by QUANTRA software as compared to visual classification. Breast (2012) 1.37

Full-field digital versus screen-film mammography: comparative accuracy in concurrent screening cohorts. AJR Am J Roentgenol (2007) 1.36

Evidence of the effect of adjunct ultrasound screening in women with mammography-negative dense breasts: interval breast cancers at 1 year follow-up. Eur J Cancer (2011) 1.33

Medical tests: women's reported and preferred decision-making roles and preferences for information on benefits, side-effects and false results. Health Expect (2002) 1.30

Breast screening with ultrasound in women with mammography-negative dense breasts: evidence on incremental cancer detection and false positives, and associated cost. Eur J Cancer (2008) 1.28

Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. Ann Surg Oncol (2014) 1.28

Dietary and lifestyle determinants of mammographic breast density. A longitudinal study in a Mediterranean population. Int J Cancer (2006) 1.26

Accuracy and underestimation of malignancy of breast core needle biopsy: the Florence experience of over 4000 consecutive biopsies. Breast Cancer Res Treat (2006) 1.22

Meta-analysis of magnetic resonance imaging in detecting residual breast cancer after neoadjuvant therapy. J Natl Cancer Inst (2013) 1.21

Benefits, harms and costs of screening mammography in women 70 years and over: a systematic review. Med J Aust (2002) 1.12

Population estimates of survival in women with screen-detected and symptomatic breast cancer taking account of lead time and length bias. Breast Cancer Res Treat (2008) 1.11

Role of ultrasound-guided fine needle cytology of axillary lymph nodes in breast carcinoma staging. Radiol Med (2004) 1.11

Comparison of standard reading and computer aided detection (CAD) on a national proficiency test of screening mammography. Eur J Radiol (2003) 1.10

Digital breast tomosynthesis might not be the optimal modality for detecting microcalcification. Radiology (2015) 1.06

On-site evaluation of percutaneous CT-guided fine needle aspiration of pulmonary lesions. A study of 321 cases. Radiol Med (2005) 1.06

Consumer information materials for diagnostic breast tests: women's views on information and their understanding of test results. Health Expect (2003) 1.04

Comparative estimation of percentage breast tissue density for digital mammography, digital breast tomosynthesis, and magnetic resonance imaging. Breast Cancer Res Treat (2013) 1.03

Breast cancer screening: the questions answered. Nat Rev Clin Oncol (2012) 1.02

The evidence base for breast cancer screening. Prev Med (2011) 1.02

Prospective study of breast tomosynthesis as a triage to assessment in screening. Breast Cancer Res Treat (2012) 1.00

Does computer-aided detection (CAD) contribute to the performance of digital mammography in a self-referred population? Breast Cancer Res Treat (2007) 0.95

Epidermal growth factor receptor and K-RAS mutations in 411 lung adenocarcinoma: a population-based prospective study. Oncol Rep (2009) 0.93

Negligible advantages and excess costs of routine addition of breast ultrasonography to mammography in dense breasts. Tumori (2008) 0.92

Accuracy of mammography, digital breast tomosynthesis, ultrasound and MR imaging in preoperative assessment of breast cancer. Anticancer Res (2014) 0.89

Axillary management in breast cancer: what's new for 2012? Breast (2012) 0.87

Overview of long term care of breast cancer survivors. Maturitas (2011) 0.86

Evaluating new screening tests for breast cancer. BMJ (2006) 0.85

Accuracy of needle biopsy of breast lesions visible on ultrasound: audit of fine needle versus core needle biopsy in 3233 consecutive samplings with ascertained outcomes. Breast (2011) 0.85

Interval breast cancers in screening: the effect of mammography review method on classification. Breast (2007) 0.85

Physical activity and mammographic breast density in a Mediterranean population: the EPIC Florence longitudinal study. Int J Cancer (2009) 0.84

Using patient management as a surrogate for patient health outcomes in diagnostic test evaluation. BMC Med Res Methodol (2012) 0.84

The role of breast MRI in clinical practice. Aust Fam Physician (2009) 0.83

Characterisation of microcalcification clusters on 2D digital mammography (FFDM) and digital breast tomosynthesis (DBT): does DBT underestimate microcalcification clusters? Results of a multicentre study. Eur Radiol (2014) 0.83

New methods give better estimates of changes in diagnostic accuracy when prior information is provided. J Clin Epidemiol (2006) 0.83

Accuracy of a preoperative model for predicting invasive breast cancer in women with ductal carcinoma-in-situ on vacuum-assisted core needle biopsy. Ann Surg Oncol (2010) 0.82

Breast fine-needle aspiration malondialdehyde deoxyguanosine adduct in breast cancer. Free Radic Res (2011) 0.82

Conventional pap smear and liquid-based cervical cytology smear: comparison from the same patient. Tumori (2002) 0.82

Role of multimedial diagnosis of breast cancer in women below 36 year of age. Radiol Med (2005) 0.81

Conventional versus digital mammography in the analysis of screen-detected lesions with low positive predictive value. Eur J Radiol (2004) 0.81

A population-based study of breast cancer prevalence in Australia: predicting the future health care needs of women living with breast cancer. BMC Cancer (2014) 0.81

The impact of different criteria for selecting information to be provided to women undergoing diagnostic breast tests. Patient Educ Couns (2008) 0.81

PSA use and incidence of prostate biopsy in the Tuscany region: is opportunistic screening discounting biopsy in subjects with PSA elevation? Tumori (2008) 0.80

Accuracy of ultrasound for predicting pathologic response during neoadjuvant therapy for breast cancer. Int J Cancer (2014) 0.80

Management of benign breast conditions. Part 2--breast lumps and lesions. Aust Fam Physician (2005) 0.80

Incorporating new technologies into clinical practice without evidence of effectiveness in prospective studies: computer-aided detection (CAD) in breast screening reinforces the need for better initial evaluation. Breast (2007) 0.80

Newly diagnosed early breast cancer - an update on pre-operative assessment and staging. Aust Fam Physician (2012) 0.80

Comparison of standard reading and computer aided diagnosis (CAD) on a proficiency test of screening mammography. Radiol Med (2003) 0.79

From clinical trials to clinical practice: predictors of response to erlotinib in advanced non-small cell lung cancer patients pretreated with chemotherapy. Tumori (2011) 0.79

Is conventional urinary cytology still reliable for diagnosis of primary bladder carcinoma? Accuracy based on data linkage of a consecutive clinical series and cancer registry. Acta Cytol (2011) 0.79

Digital Breast Tomosynthesis (DBT) to Characterize MRI-Detected Additional Lesions Unidentified at Targeted Ultrasound in Newly Diagnosed Breast Cancer Patients. Eur Radiol (2015) 0.78

Clinical significance and optimal management of patients with an "atypia, probably benign" (C3) report at FNAC of the breast. Breast J (2004) 0.78

Analysis of morphologic patterns of fine-needle aspiration of the breast to reduce false-negative results in breast cytology. Cancer (2005) 0.78

Non-malignant breast papillary lesions - b3 diagnosed on ultrasound--guided 14-gauge needle core biopsy: analysis of 114 cases from a single institution and review of the literature. Pathol Oncol Res (2015) 0.78

Comparison of two commercial systems for computer-assisted detection (CAD) as an aid to interpreting screening mammograms. Radiol Med (2004) 0.77

Early detection of breast cancer the second time around: mammography in women with a personal history of breast cancer. Med J Aust (2011) 0.77

Bigger margins are not better in breast conserving surgery. BMJ (2012) 0.76

Participation and risk of high grade cytological lesions among immigrants and Italian-born women in an organized cervical cancer screening program in Central Italy. J Immigr Minor Health (2015) 0.76

Glycemic index, glycemic load and mammographic breast density: the EPIC Florence longitudinal study. PLoS One (2013) 0.76

Mammographic features of breast cancer in young symptomatic women. Australas Radiol (2003) 0.75

Ultrasound and mammography for breast cancer screening. JAMA (2008) 0.75

Technical aspects of breast MRI--do they affect outcomes? Eur Radiol (2009) 0.75

Evaluation of lesions of uncertain malignant potential (B3) at core needle biopsy using magnetic resonance imaging: a new approach warrants prospective studies. Breast (2008) 0.75

Management of lesions of uncertain malignant potential on breast core needle histology: vacuum-assisted excision as an alternative to surgical excision. Breast (2008) 0.75

Computer-aided screening mammography. N Engl J Med (2007) 0.75

The DAMA trial: a diet and physical activity intervention trial to reduce mammographic breast density in postmenopausal women in Tuscany, Italy. Study protocol and baseline characteristics. Tumori (2014) 0.75

Should women at high risk of breast cancer have screening magnetic resonance imaging (MRI)? Breast (2006) 0.75

Breast imaging and needle biopsy in women with clinically evident breast cancer: does combined imaging change overall diagnostic sensitivity? Breast (2007) 0.75

STORM, a new dimension for mammography screening. Med J Aust (2013) 0.75